Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cells

Clinical and Experimental Gastroenterology

Volumn 5, Issue 1, 2012, Pages 61-67

  Frasca, Giuseppina ^a   Cardile, Venera ^a   Puglia, Carmelo ^a   Bonina, Claudia ^a   Bonina, Francesco ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Caco 2; ICAM 1; IL 8; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; GELATIN TANNATE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; TASECTAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

EID: 84864072968     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S28792     Document Type: Article

References (40)

1. MacDermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol. 1996;31(6):907-916.
2. Huang Y, Li N, Liboni K, Neu J. Glutamine decreases lipopolysaccharide-induced IL-production in Caco-2 cells through a non-NF-kappaB p50 mechanism. Cytokine. 2003;22(3-4):77-83.
3. Eckmann L, Jung HC, Schürer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology. 1993;105(6):1689-1697.
4. Walker WA. Role of nutrients and bacterial colonization in the development of intestinal host defense. J Pediatr Gastroenterol Nutr. 2000; 30(Suppl 2):S2-S7.
5. Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs. 2005;65(16):2253-2286.
6. Yoshida T, Amakura Y, Yoshimura M. Structural features and biological properties of ellagitannins in some plant families of the order myrtales. Int J Mol Sci. 2010;11(1):79-106.
7. Yoshida T, Hatano T, Ito H. High molecular weight plant polyphenols (tannins): Prospective functions. Recent Adv Phytochemistry. 2005;39:163-190.
8. Zhang J, Li L, Kim SH, Hagerman AE, Lü J. Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloylglucose. Pharm Res. 2009;26(9):2066-2080.
9. Feldman KS, Sahasrabudhe K, Lawlor MD, Wilson SL, Lang CH, Scheuchenzuber WJ. In vitro and in vivo inhibition of LPSstimulated tumor necrosis factor-alpha secretion by the gallotannin beta-D-pentagalloylglucose. Bioorg Med Chem Lett. 2001;11(14): 1813-1815.
10. Kang DG, Moon MK, Choi DH, Lee JK, Kwon TO, Lee HS. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-Ogalloyl-beta-D-glucose (PGG) via a nitric oxide-cGMP pathway. Eur J Pharmacol. 2005;524(1-3):111-119.
11. Akiyama H, Fujii K, Yamasaki O, Oono T, Iwatsuki K. Antibacterial action of several tannins against Staphylococcus aureus. J Antimicrob Chemother. 2001;48(4):487-491.
12. Chung KT, Wong TY, Wei CI, Huang YW, Lin Y. Tannins and human health: a review. Crit Rev Food Sci Nutr. 1998;38(6):421-464.
13. Kaur S, Grover IS, Singh M, Kaur S. Antimutagenicity of hydrolyzable tannins from Terminalia chebula in Salmonella typhimurium. Mutat Res. 1998;419(1-3):169-179.
14. Shi TS. Use of combined traditional Chinese and western medicine in the management of burns. Panminerva Med. 1983;25(3):197-202.
15. Khan NS, Ahmad A, Hadi SM. Anti-oxidant, pro-oxidant properties of tannic acid and its binding to DNA. Chem Biol Interact. 2000;125(3):177-189.
16. Sanchez-Moreno C, Larrauri AJ, Saura-Calixto F. Free radical scavenging capacity and inhibition of lipid oxidation of wines, grape juices and related polyphenolic constituents-history, production and role in disease prevention. Food Res Int. 1999;32(6):407-412.
17. Chung KT, Stevens SE Jr, Lin WF, Wei CI. Growth inhibition of selected foodborne bacteria by tannic acid, propyl gallate and related compounds. Lett Appl Microbiol. 1993;17(1):29-32.
18. Chung KT, Lu Z, Chou MW. Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. Food Chem Toxicol. 1998;36(12):1053-1060.
19. Scalbert A. Antimicrobial properties of tannins. Phytochemistry. 1991;30(12):3875-3883.
20. Taguri T, Tanaka T, Kouno I. Antimicrobial activity of 10 different plant polyphenols against bacteria causing food-borne disease. Biol Pharm Bull. 2004;27(12):1965-1969.
21. Loeb H, Vandenplas Y, Würsch P, Guesry P. Tannin-rich carob pod for the treatment of acute-onset diarrhea. J Pediatr Gastroenterol Nutr. 1989;8(4):480-485.
22. Esteban Carretero J, Durbán Reguera F, López-Argüeta Alvarez S, López Montes J. A comparative analysis of response to ORS (oral rehydration solution) vs ORS gelatin tannate in two cohorts of pediatric patients with acute diarrhea. Rev Esp Enferm Dig. 2009;101(1):41-48.
23. Brandtzaeg P. Molecular and cellular aspects of the secretory immunoglobulin system. APMIS. 1995;103(1):1-19.
24. Gibson P, Anderson R, Mariadason J, Wilson AJ. Protective role of the epithelium of the small intestine and colon. Inflamm Bowel Dis. 1996;2(4):279-302.
25. Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 2001;250(2):91-104.
26. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr. 2001;160(8):457-463.
27. Vignola AM, Chanez P, Campbell AM, et al. Quantification and localization of HLADR and intercellular adhesion molecule-1 (ICAM-1) molecules on bronchial epithelial cells of asthmatics using confocal microscopy. Clin Exp Immunol. 1994;96(1):104-109.
28. Elgavish A. Effects of Escherichia coli and E. coli lipopolysaccharides on the function of human ureteral epithelial cells cultured in serum-free medium. Infect Immun. 1993;61(8):3304-3312.
29. Chan RD, Greenstein SM, Sablay L, et al. Analysis of adhesion molecule expression by tubular epithelial cells using urine immunocytology. Acta Cytol. 1995;39(3):435-442.
30. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8(8):504-512.
31. Simmons DL. The role of ICAM expression in immunity and disease. Cancer Surv. 1995;24:141-155.
32. Kelly CP, O'Keane JC, Orellana J, et al. Human colon cancer cells express ICAM-1 in vivo and support LFA-1 dependent lymphocyte adhesion in vitro. Am J Physiol. 1992;263(6 Pt 1):G864-G867.
33. Huang GT, Eckmann L, Savidge TC, Kagnoff MF. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion. J Clin Invest. 1996;98(2):572-583.
34. Mensa L, Marco F, Vila J, Gascón J, Ruiz J. Quinolone resistance among Shigella spp. isolated from travellers returning from India. J Clin Microbiol Infect. 2008;14(3):279-281.
35. Li ST, Grossman DC, Cummings P. Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Med. 2007;4(3):e98.
36. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369(9573): 1641-1657.
37. Ghosh S, Panaccione R. Anti-adhesion molecule therapy for inflammatory bowel disease. Therap Adv Gastroenterol. 2010;3(4): 239-358.
38. Brynskov J, Foegh P, Pedersen G, et al. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut. 2002;51(1):37-43.
39. Perrier C, Rutgeerts P. Cytokine blockade in inflammatory bowel diseases. Immunotherapy. 2011;3(11):1341-1352.
40. Magro F, Portela F. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. BioDrugs. 2010;24 Suppl 1:3-14.